Literature DB >> 8412998

Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus.

V Broadbent1, D B Dunger, E Yeomans, B Kendall.   

Abstract

In order to document anterior pituitary dysfunction in patients with biopsy-proven Langerhans cell histiocytosis (LCH) and diabetes insipidus and to correlate this with structural changes on imaging, we performed an insulin tolerance test, enhanced computed tomography (CT), and unenhanced magnetic resonance imaging (MRI) in nine patients. Six of the nine patients had growth hormone deficiency, which in two patients was part of panhypopituitarism and in one was associated with poor cortisol response to insulin hypoglycemia. One patient had an exaggerated growth hormone response and one who had had neck irradiation as an infant, had a high resting thyroid stimulating hormone (TSH) suggesting compensated primary hypothyroidism. All enhanced CTs were abnormal, bony defects being the only abnormality in two patients and opaque mastoids in one. The remaining six patients all had structural changes in the hypothalamic/pituitary region. Unenhanced MRI confirmed the CT findings except in one child who had been treated with radiotherapy in the intervening period, but, in addition, confirmed diabetes insipidus by showing absence of the posterior pituitary bright signal and picked up white matter changes in a child with clinical neurological dysfunction. Our findings indicate that the development of diabetes insipidus in LCH is commonly associated with anterior pituitary dysfunction and is usually associated with structural changes in the hypothalamic/pituitary axis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412998     DOI: 10.1002/mpo.2950210908

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  7 in total

1.  Diabetes insipidus for five years preceding the diagnosis of hypothalamic Langerhans cell histiocytosis.

Authors:  P F Catalina; M Rodr'iguez Garc'ia; C de la Torre; C P'aramo; R V Garc'ia-Mayor
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH).

Authors:  P Makras; C Samara; M Antoniou; A Zetos; D Papadogias; Z Nikolakopoulou; E Andreakos; G Toloumis; G Kontogeorgos; G Piaditis; G A Kaltsas
Journal:  Neuroradiology       Date:  2005-11-15       Impact factor: 2.804

3.  Langerhans cell histiocytosis and pituitary function.

Authors:  Polyzois Makras; Gregory Kaltsas
Journal:  Endocrine       Date:  2015-01-01       Impact factor: 3.633

4.  Neurodegeneration in the course of Langerhans cell histiocytosis.

Authors:  F Spagnolo; E Leopizzi; R Cardamone; M Falautano; V Martinelli; G Comi; M A Volonté
Journal:  Neurol Sci       Date:  2011-07-09       Impact factor: 3.307

5.  Growth hormone replacement in patients with Langerhan's cell histiocytosis.

Authors:  S J Howell; P Wilton; S M Shalet
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

6.  Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus.

Authors:  K D Lin; J D Lin; H H Hsu; J H Juang; M J Huang; H S Huang
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

7.  The pituitary gland in patients with Langerhans cell histiocytosis: a clinical and radiological evaluation.

Authors:  Neslihan Kurtulmus; Meral Mert; Refik Tanakol; Sema Yarman
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.